Interest in oncology is on the rise as the blockbuster drug era breathes its last, and this has altered marketing in cancer care.
Top 25 oncology products in 2015
July 25, 2016
12:00 pm
Despite the arrivals of new drugs, Genentech continues to be the market leader. Its drugs, Rituxan, Avastin, and Herceptin, are the category leaders, generating a total of $9.29 billion in sales.
CAR-T therapies: the future of cancer care, or an industry pipe dream?
Even as Gilead prepares to launch a third hepatitis-C product, drugs offering better antimicrobial resistance are angling for their own moments in the spotlight.
Fueled by precision medicine, drugmakers delve deeper in autoimmune diseases